338 related articles for article (PubMed ID: 12866365)
1. Injectable drugs: the new frontier in pharmacy management.
Rodgers JR
Am J Manag Care; 2003 Jun; Suppl Decision Maker News():5-8. PubMed ID: 12866365
[No Abstract] [Full Text] [Related]
2. The pitfalls and potential of pharmacy risk.
Lawrence J
Manag Care; 1998 May; 7(5):45-6, 51-2. PubMed ID: 10180140
[No Abstract] [Full Text] [Related]
3. Managing injectable drugs: an evolving challenge for pharmacy benefit managers.
Giaquinta D
Manag Care Interface; 2002 Dec; 15(12):15-6. PubMed ID: 12530291
[No Abstract] [Full Text] [Related]
4. Managed care pharmacy 101: learning from the students.
Penna P
Manag Care Interface; 2005 Apr; 18(4):28, 31. PubMed ID: 15889760
[No Abstract] [Full Text] [Related]
5. Designing and implementing an effective specialty pharmacy service program.
Morrow TJ
Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
[TBL] [Abstract][Full Text] [Related]
6. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
Navarro RP
Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
[No Abstract] [Full Text] [Related]
7. Changing the marketing message.
Navarro RP
Med Interface; 1995 Jun; 8(6):83-5. PubMed ID: 10142946
[No Abstract] [Full Text] [Related]
8. Managed care organizations: an introduction--Part II of II.
Vogenberg FR
Hosp Pharm; 1995 Feb; 30(2):138, 140-2. PubMed ID: 10184282
[No Abstract] [Full Text] [Related]
9. Specialty pharmacy management adjusts to new financial realities.
Reinke T
Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
[No Abstract] [Full Text] [Related]
10. Developing a management plan.
Willcutts D
Manag Care Q; 2003; 11(1):7-10. PubMed ID: 12790060
[TBL] [Abstract][Full Text] [Related]
11. Sorting out contradictions within managed care.
Navarro RP
Med Interface; 1996 Sep; 9(9):85-6. PubMed ID: 10161524
[No Abstract] [Full Text] [Related]
12. Plans should harness PBMs to help educate customers.
Gibson T
Manag Care; 2003 Mar; 12(3):8, 11. PubMed ID: 12685369
[No Abstract] [Full Text] [Related]
13. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
Kuhlik BN
Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
[No Abstract] [Full Text] [Related]
14. Specialty pharmaceuticals: developing a management plan.
Willcutts D
Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
[TBL] [Abstract][Full Text] [Related]
15. The three dimensions of managed care pharmacy practice.
Gouveia WA; Shane R
Am J Manag Care; 1997 Feb; 3(2):231-9. PubMed ID: 10169257
[TBL] [Abstract][Full Text] [Related]
16. The impact of managed care on pharmacy practice.
Schafermeyer KW
Pharm Pract Manag Q; 2000 Jan; 19(4):99-116. PubMed ID: 10787569
[TBL] [Abstract][Full Text] [Related]
17. Legislative challenges facing managed care pharmacy.
Epstein L
Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
[No Abstract] [Full Text] [Related]
18. Strategies for managing injectable drugs in a managed care setting.
Tercero W
Manag Care Q; 2002; 10(3):16-20. PubMed ID: 12476661
[TBL] [Abstract][Full Text] [Related]
19. Reinventing the PBM (pharmacy benefit manager).
Marcille JA; Wynn P
Manag Care; 1997 Apr; 6(4):64-6, 75-8. PubMed ID: 10167003
[No Abstract] [Full Text] [Related]
20. Unlocking the secrets of restrictive formularies.
Kassberg M
Manag Care; 1994 Dec; 3(12):15-8, 20-1. PubMed ID: 10154852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
